Funds holding ASCENTAGE PHARMA GROUP INTERNATIONAL
ISIN US04390B1052 · Cayman Islands · LEI 300300WBVGZIXEF27W64
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 8.5K $
A single tracked fund declares this company. So these figures do not say who owns it.
This issuer has other securities : Ascentage Pharma Group International (KYG0519B1023)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 361 | 8.5K $ | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | -2 | 361 | -97.5 % |
| 2026Q1 | 3 | 0 | 14,703 | -25.1 % |
| 2025Q4 | 3 | +2 | 19,643 | +1,910.5 % |
| 2025Q3 | 1 | 977 |
Institutional managers
6 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Point72 Asset Management, L.P. | 16,056 | 383.3K $ | as of Mar 31, 2026 |
| XY Capital Ltd | 13,014 | 310.6K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 518 | 12.4K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 498 | 11.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 124 | 3K $ | as of Mar 31, 2026 |
| EverSource Wealth Advisors, LLC | 24 | 573 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding ASCENTAGE PHARMA GROUP INTERNATIONAL". https://titelia.com/en/stocks/ascentage-pharma-group-international-US04390B1052